Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 24 Issue 11, November 2022

SARS-CoV-2

Tanaka et al. generate salivary gland organoids from human induced pluripotent stem cells that serve as a model for salivary gland development and SARS-CoV-2 infection.

See Tanaka et al.

Image: Image courtesy of Junichi Tanaka, Showa University. Cover Design: Lauren Heslop.

Editorial

Top of page ⤴

Comment

  • Publicly shared metabolomics data may contain key answers to central questions in cell biology, but re-use of the data is complicated by the lack of standardized experimental and computational methods in the field. This Comment provides some tips to help ensure that shared metabolomics data are re-used appropriately.

    • Ethan Stancliffe
    • Gary J. Patti
    Comment
Top of page ⤴

News & Views

  • FG-nucleoporins of the nuclear pore complexes form a permeability barrier between the nucleus and the cytosol. FG-nucleoporins contain disordered regions and are prone to aggregation. Two studies identify the chaperone DNAJB6 as a key factor that prevents aggregation of FG-nucleoporins and assists in the biogenesis of nuclear pore complexes.

    • Janine Kirstein
    News & Views
  • PTEN, a tumour suppressor, also regulates T cell activation. A new study reports that PTEN acts as a cell-intrinsic rheostat linking TCR- and IL-23-mediated signalling to regulate development of type-17 innate-like T cells in the thymus. This work may have important implications for treating autoimmune and inflammatory diseases.

    • Nikolaos Patsoukis
    • Vassiliki A. Boussiotis
    News & Views
  • In tumours, cancer cells can overcome energy stress via differential regulation of non-canonical ‘moonlighting’ functions of metabolic enzymes. A study now shows that the metabolic phosphatase fructose-1,6-bisphosphatase 1 (FBP1) can act as a nuclear protein phosphatase and reveals how this process is inhibited in cancer cells.

    • Scott A. Gerber
    • Arminja N. Kettenbach
    News & Views
  • Several new technologies have used synthetic RNAs that leverage the cell’s RNA splicing machinery to drive the expression of gene products. A new study now reports a technique to dynamically and non-invasively monitor gene expression by embedding reporters within introns contained in the parent gene.

    • Salima Benbarche
    • Omar Abdel-Wahab
    News & Views
Top of page ⤴

Review Articles

Top of page ⤴

Letters

Top of page ⤴

Articles

Top of page ⤴

Technical Reports

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links